CA2662636A1 - Compositions de n-acetylcysteine et methodes pour traiter des exacerbations aigues de maladies pulmonaires inflammatoires - Google Patents

Compositions de n-acetylcysteine et methodes pour traiter des exacerbations aigues de maladies pulmonaires inflammatoires Download PDF

Info

Publication number
CA2662636A1
CA2662636A1 CA 2662636 CA2662636A CA2662636A1 CA 2662636 A1 CA2662636 A1 CA 2662636A1 CA 2662636 CA2662636 CA 2662636 CA 2662636 A CA2662636 A CA 2662636A CA 2662636 A1 CA2662636 A1 CA 2662636A1
Authority
CA
Canada
Prior art keywords
acetylcysteine
agent
pharmaceutically acceptable
disease
nac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2662636
Other languages
English (en)
Other versions
CA2662636C (fr
Inventor
Rabindra Tirouvanziam
Leonore A. Herzenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of CA2662636A1 publication Critical patent/CA2662636A1/fr
Application granted granted Critical
Publication of CA2662636C publication Critical patent/CA2662636C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention porte sur des compositions de N-acétylcystéine et des méthodes de traitement de déséquilibre dinflammation et doxydoréduction dans les exacerbations aiguës de maladie pulmonaire inflammatoire.
CA2662636A 2008-04-15 2009-04-15 Compositions de n-acetylcysteine et methodes pour traiter des exacerbations aigues de maladies pulmonaires inflammatoires Active CA2662636C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4494308P 2008-04-15 2008-04-15
US61/044,943 2008-04-15

Publications (2)

Publication Number Publication Date
CA2662636A1 true CA2662636A1 (fr) 2009-10-15
CA2662636C CA2662636C (fr) 2017-01-24

Family

ID=41180997

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2662636A Active CA2662636C (fr) 2008-04-15 2009-04-15 Compositions de n-acetylcysteine et methodes pour traiter des exacerbations aigues de maladies pulmonaires inflammatoires

Country Status (1)

Country Link
CA (1) CA2662636C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010048716A1 (fr) * 2008-10-29 2010-05-06 Pacific Therapeutics Ltd. Composition et procédé de traitement d'une fibrose
US11918552B2 (en) 2016-12-15 2024-03-05 Zambon S.P.A. N-acetylcysteine for use as antibacterial agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010048716A1 (fr) * 2008-10-29 2010-05-06 Pacific Therapeutics Ltd. Composition et procédé de traitement d'une fibrose
US11918552B2 (en) 2016-12-15 2024-03-05 Zambon S.P.A. N-acetylcysteine for use as antibacterial agent

Also Published As

Publication number Publication date
CA2662636C (fr) 2017-01-24

Similar Documents

Publication Publication Date Title
US20090192227A1 (en) N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease
CA2620123C (fr) Methodes de traitement et de surveillance de l'inflammation et du desequilibre d'oxydoreduction dans la mucoviscidose
EP2589381B1 (fr) Compositions pour améliorer ou préserver une fonction de poumons chez un patient souffrant de troubles pulmonaires
Schuster et al. Neutrophil elastase stimulates tracheal submucosal gland secretion that is inhibited by ICI 200,355
KR20170095894A (ko) 암모니아-저감 치료를 이용한 간성상세포 활성화와 연관된 질병의 치료
US20110014285A1 (en) N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
US20220062203A1 (en) N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3' disulfanediyl BIS(2-Acetamidopropanamide) (DINACA) for the Prevention and Treatment of Radiation Pneumonitis and Treatment of Pulmonary Function in Cystic Fibrosis
CN116234563A (zh) 抗致病治疗方法
CN101820753A (zh) 通过增量或减量调节哺乳动物细胞中的炎性介质的本地体内水平来治疗哺乳动物中的肺部疾病状态的方法
CN114126643A (zh) 包含溶菌酶的广谱抗菌药物制剂及其使用方法
JP2004531539A (ja) 非感染性炎症性疾患を治療するためのアジスロマイシンの新規治療適応
ES2374399T3 (es) Piridoxamina para uso en el tratamiento de nefropatía diabética en diabetes tipo ii.
JP2009102248A (ja) 血中尿酸を急速に低減させるための医薬組成物およびパッケージならびに血中尿酸を急速に低減させるためのアンセリンの使用
Basak et al. Malabaricone C attenuates nonsteroidal anti-inflammatory drug-induced gastric ulceration by decreasing oxidative/nitrative stress and inflammation and promoting angiogenic autohealing
CA2662636C (fr) Compositions de n-acetylcysteine et methodes pour traiter des exacerbations aigues de maladies pulmonaires inflammatoires
Shetty et al. Mechanisms and therapeutics of n-acetylcysteine: a recent update
JP2023531872A (ja) 急性呼吸窮迫症候群、喘息、又はアレルギー性鼻炎を治療するための製剤及び方法
US20070021508A1 (en) Method for treatment of Helicobacter pylori infection and/or an associated disease
US20100158857A1 (en) Compositions and methods for the inhibition of endothelial nitric oxide synthase activity
Narasimhan et al. New and investigational treatments in cystic fibrosis
CA3144374A1 (fr) Traitement comprenant des inhibiteurs de sglt, par exemple des inhibiteurs de sglt 1/2
CN102858329B (zh) 用于治疗疾病的化合物
WO2021252378A1 (fr) Prévention ou traitement de la covid-19
EP4135685A1 (fr) Inhibiteurs de protéases à cystéine destinés à être utilisés dans la prévention et/ou le traitement d'un coronavirus
Bao et al. Oxalate nephropathy and the mechanism of oxalate-induced kidney injury

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140116